Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer-Reference-Cited by-同舟云学术

Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer

Published:2019-04-02 Issue:13 Volume:25 Page:3934-3945
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Seo Yongwoo David,Jiang Xiuyun,Sullivan Kevin M.,Jalikis Florencia G.,Smythe Kimberly S.,Abbasi Arezou,Vignali Marissa,Park James O.,Daniel Sara K.,Pollack Seth M.,Kim Teresa S.,Yeung Raymond,Crispe Ian Nicholas,Pierce Robert H.,Robins Harlan,Pillarisetty Venu G.

Funder

NIH

Parvin Valentini Fund for Pancreatic Cancer Research, Donald E. Bocek Endowed Research Development Award in Pancreatic CancerUnited States Army Medical Research Acquisition Activity

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies in hepatopancreatobiliary cancers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8+ cytotoxic T cell recruitment to pancreatic tumours;Frontiers in Immunology;2024-08-05

3. Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma;Cellular Oncology;2024-07-15

4. Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancer;Proceedings of the National Academy of Sciences;2024-07-09

5. Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy;Science Advances;2024-07-05